Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience

Overview of attention for article published in Hematology Transfusion and Cell Therapy, February 2021

Altmetric Badge

Mentioned by

news: 3 news outlets

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 12 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment

Oncology Nursing News, 26 Feb 2024

Adding the antifungal prophylaxis azoles to either ruxolitinib (Jakafi) or best available therapy (BAT) did not impact outcomes…

Ruxolitinib Plus Antifungal Azoles Do Not Impact Acute GVHD Outcomes

Cancer Network, 24 Feb 2024

Twenty-nine patients given azoles discontinued ruxolitinib treatment because they completed the study treatment compared with 4…

Concomitant Azoles Does Not Affect Clinical Outcomes With Ruxolitinib in Acute GVHD

OncLive, 23 Feb 2024

Zahra Mahmoudjafair, PharmD, BCOP Patients with acute steroid-refractory graft-vs-host-disease (GVHD) treated with ruxolitinib (J…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.